Synopsis
Distinguish clinically important incidental findings from low-value observations, apply finding-specific guidance, and create named ownership from report acknowledgment through patient communication and completed follow-up.
- A report that has been issued or viewed is not complete care: acknowledgment, interpretation, action, patient communication and tracked completion are separate steps.
- The requesting or responsible clinical team owns reading and action, while the healthcare organisation must provide a failsafe for unacknowledged or unactioned reports.
- There is no universal incidental-lesion interval; use the relevant organ- and finding-specific guideline with imaging features, prior studies and patient risk.
Key red flags
Incidental pulmonary embolism, perforation, major haemorrhage, unstable fracture or another immediately harmful finding requires urgent direct communication.
A suspected new cancer or recurrence requires an alert and an owned diagnostic pathway even when discovered unexpectedly.
A recommended follow-up has no named team, date, tracking mechanism or patient communication plan.
The patient has been discharged, transferred or lost between organisations before the report was acknowledged.
Although unrelated to the request, the abnormality may cause immediate harm and requires direct clinical communication and documented acknowledgment.
Reasoning priorities
Establish chronicity, growth and previous characterisation.
Long-term stability may reduce concern, whereas interval growth can change urgency; confirm comparable technique and anatomy.
Worked reasoning
A report recommends nodule assessment after the patient has left the acute service.
- Context: verify patient identity, report details, prior thoracic imaging, risk history and the team currently responsible for care.
- Reasoning: apply the appropriate nodule guideline only after confirming morphology, measurement, exclusions and patient treatment fitness.
- Outcome: a named clinician explains the finding, arranges the indicated comparison, clinic or surveillance, and records a due date.
- Verification: the tracking system confirms completion, review of the new result, patient communication and documented pathway closure or continuation.